ClinConnect ClinConnect Logo
Search / Trial NCT06294405

Intraocular Lens Implant Registry Study

Launched by UNIVERSITY HOSPITAL AUGSBURG · Mar 4, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Intraocular Lens Implant Registry Study is a research project aimed at improving the outcomes of intraocular lens implants used during cataract surgery. The study is focused on understanding complications related to these lenses, such as rotation, inflammation, and cloudiness. It is currently recruiting participants, and anyone aged 18 or older who has received an intraocular lens implant is eligible to join, as long as they can provide consent and do not have conditions like dementia or are pregnant or breastfeeding.

Participants in this study can expect to share their experiences and any issues they may have encountered with their lens implants. The information collected will help researchers enhance the effectiveness of these devices and potentially lead to better results for future patients undergoing cataract surgery. If you or a family member fit the eligibility criteria, this could be a great opportunity to contribute to important medical research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Treatment with an intraocular lens implant 18 years of age or older Patient consent Full legal capacity
  • Exclusion Criteria:
  • Dementia Pregnancy Breastfeeding

About University Hospital Augsburg

University Hospital Augsburg is a leading academic medical center located in Augsburg, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between multidisciplinary teams of researchers, clinicians, and patients. With a commitment to enhancing patient outcomes and contributing to the global medical community, University Hospital Augsburg emphasizes ethical standards, patient safety, and the development of novel therapeutic approaches in various fields of medicine.

Locations

Augsburg, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported